@doctor.sina: Zepbound (tirzepatide) is the first FDA-approved medication for moderate-to-severe obstructive sleep apnea — but there's a lot people get wrong. 1. Some people should avoid it. 🚫 Absolute no (per the FDA label): personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN2), or a serious allergic reaction to tirzepatide. It carries the FDA's boxed warning — its strongest — for a rare thyroid tumor seen in animal studies. ⚠ Talk first: history of pancreatitis, gallbladder disease, or severe gastroparesis (slow stomach emptying) — these weren't studied in the trials. 2. It's likely long-term. A JAMA study (SURMOUNT-4) found most people regained the majority of lost weight within a year of stopping — and the metabolic benefits reversed too. This isn't a quick reset. 3. The practical stuff: weekly injection, mostly stomach-related side effects that ease over time, and coverage varies a lot by plan. Have OSA and obesity? Bring these three to your sleep physician, starting with your family thyroid history. 👇 #zepbound #tirzepatide #sleepapnea #OSA #weightloss

Doctor Sina

Open In TikTok:

Region: US

Wednesday 03 June 2026 23:30:00 GMT